RINALDI, Luca
 Distribuzione geografica
Continente #
EU - Europa 630
NA - Nord America 459
AS - Asia 370
AF - Africa 347
SA - Sud America 6
Totale 1.812
Nazione #
US - Stati Uniti d'America 434
RU - Federazione Russa 392
CI - Costa d'Avorio 338
SG - Singapore 318
NL - Olanda 34
CZ - Repubblica Ceca 32
DE - Germania 32
IT - Italia 29
IE - Irlanda 23
GB - Regno Unito 21
CN - Cina 20
CA - Canada 15
LT - Lituania 14
HK - Hong Kong 11
ES - Italia 10
FI - Finlandia 10
UA - Ucraina 9
EG - Egitto 8
BE - Belgio 7
IN - India 4
PA - Panama 4
BG - Bulgaria 3
BO - Bolivia 3
HU - Ungheria 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
BZ - Belize 2
ID - Indonesia 2
JM - Giamaica 2
LU - Lussemburgo 2
PE - Perù 2
PH - Filippine 2
VN - Vietnam 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FR - Francia 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.812
Città #
Abidjan 338
Singapore 182
Dallas 105
New York 98
Moscow 41
Boardman 38
Amsterdam 31
Brno 26
Frankfurt am Main 25
Dublin 23
Los Angeles 17
West Jordan 14
Hong Kong 11
Lappeenranta 8
Ottawa 8
Brussels 7
London 7
Toronto 7
Damietta 6
Munich 6
Córdoba 5
Olomouc 5
Rome 4
Casoria 3
La Paz 3
Milan 3
San Francisco 3
Sofia 3
Sopron 3
Bari 2
Beijing 2
Bragança 2
Cairo 2
Chicago 2
Dubai 2
Fort Wayne 2
Helsinki 2
Huelva 2
Hyderabad 2
Kunming 2
Lima 2
Luxembourg 2
Manila 2
Málaga 2
Newark 2
Salerno 2
Shanghai 2
Ashburn 1
Ashgabat 1
Baku 1
Buenos Aires 1
Campobasso 1
Casavatore 1
Civitacampomarano 1
Dalian 1
Forest City 1
Fort Worth 1
Ho Chi Minh City 1
Huntsville 1
Jakarta 1
Lisbon 1
Malang 1
Mexico City 1
Murcia 1
Naples 1
Panama City 1
Parma 1
Phnom Penh 1
Prague 1
Prineville 1
Pune 1
Reston 1
Riga 1
Riyadh 1
Scandicci 1
Shenzhen 1
Taipei 1
Tallinn 1
Tashkent 1
Vientiane 1
Washington 1
Wuhu 1
Wuxi 1
Yerevan 1
Zagreb 1
Totale 1.104
Nome #
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 25
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 23
A gene and epigenetic combination therapy for liver cancer treatment 22
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 21
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 21
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 20
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 20
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 19
A genic and epigenetic combination therapy for liver cancer 18
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 18
[Next Generation Sequencing and ADPKD] 18
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 18
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 17
A suspected infective endocarditis in patients with a history of chronic HCV infection 17
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 16
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 16
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 15
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 14
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 14
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 14
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 14
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 14
Sonoporation by microbubbles as gene therapy approach for liver cancer 14
Antibiotic use and associated factors in a large sample of hospitalised older people 14
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 14
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 13
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 13
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 13
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 13
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 13
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 13
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 13
Advances in Nanomedicine for Precision Insulin Delivery 13
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 12
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 12
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 12
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 12
Twelve-week course of pIFN-a-2a/ribavirin is an optimized regimen for treatment of HCV genotype 2 but not genotype 3 non-cirrhotic patients with RVR 12
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 11
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 11
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 11
Characteristics and outcome of cryptogenic cirrhosis in Italy 11
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 11
Cardiovascular benefits from gliflozins: Effects on endothelial function 11
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: Incidence, characteristics, risk factors and survival 11
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 11
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 11
HCV-related steatosis and risk of atherosclerosis 11
Lactate in pleural and abdominal effusions 10
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 10
L'indagine medico-nucleare delle masse timiche 10
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 10
Management of HBV infection in oncohematologic immunosuppressed patients: lamivudine prohylaxis and rescue therapy of occult HBV infection 10
Late HCC onset after DAAs therapy in patients with SVR: A type D ADR that requires a longer follow-up? 10
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 10
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: incidence, characteristics, risk factors and survival 10
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 9
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 9
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 9
Preliminary experience of treatment with teriparatide of post-severe osteoporosis unresponsive to standard therapy 9
Hepatic Steatosis And necro-Inflammatory Activity overestimate Liver Stiffness by Transient Elastography in Staging Liver Fibrosis in Chronic Hepatitis C 9
Metformin: An old drug against old age and associated morbidities 9
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 9
Transient elastography has a practical role in monitoring liver transplanted patients: preliminary results from experience in a real world setting 9
Different serological, molecular and cytokine profiles characterize active and inactive disease patients with chronic hepatitis B virus (HBV infection) 9
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 9
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 9
Influence of ITPase activity on decreases of hemoglobin during treatment with interferon-free DAA based and ribavirin in HCV related cirrhosis 9
L'indagine medico-nucleare dei tumori del pancreas endocrino 9
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 9
HCV-related steatosis and risk of atherosclerosis 9
HCC recurrence after DAA treatment in HCV patients 8
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 8
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 8
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 8
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 8
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 8
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 8
Antioxidant diet and genotyping as tools for the prevention of liver disease 8
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 8
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 8
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 8
Chronic Hepatitis C Virus Infection and Depression 8
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico 8
Influenza virus infections: clinical update, molecular biology, and therapeutic options 8
What changed in the Italian internal medicine and geriatric wards during the lockdown 7
Regulation of m6A methylation as a new therapeutic option against COVID-19 7
Management of symptomatic osteoporosis after liver tranplantation in a real-world setting 7
Lactate determination in pleural and abdominal effusions: a quick diagnostic marker of exudate—a pilot study 7
Percutaneous implant of Denver peritoneovenous shunt for treatment of refractory ascites. 7
Sonoporation by microbubbles as gene therapy approach against liver cancer 7
HCV infection impairs glucose metabolism which promotes a more aggressive course of liver disease and metabolic syndrome 7
HCC recurrence after DAA treatment in HCV patients 7
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 7
Relevance of lung ultrasound in diagnostic algohortim in the respiratory diseases: a multicentre prospective study 7
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 7
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 7
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 7
Hepatocellular carcinoma and non alcoholic fatty liver disease; a dangerous liaison 7
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 6
Totale 1.141
Categoria #
all - tutte 24.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024334 0 0 0 0 2 151 11 44 5 17 20 84
2024/20251.501 520 223 254 23 416 65 0 0 0 0 0 0
Totale 1.835